ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2025
Demand for heroin in rats: effects of non-drug alternative substitutes and complements.
Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Behavioral economic demand for ethanol in Long Evans rats: Influence of choice context, sex, and vapor history.Psychopharmacology · 2026Article
- Preclinical abuse potential testing using behavioral economics and drug self-administration demand-curve analysis: A strategy to improve resolution of drug stratification for regulatory control.Pharmacological reviews · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Given the central role of economic demand for drugs in substance use disorder, identifying factors that increase or decrease drug value is of high importance. The present study investigated how the concurrent availability of non-drug reinforcers previously shown to be heroin substitutes or complements affected demand for heroin in rats. In Exp. 1, three groups of rats pressed one lever for intravenous heroin infusions on a series of prices that increased over sessions. The groups differed with respect to what they received for pressing a second lever: timeout-from-avoidance (TOA) reinforcers, heroin at a constant low price, or no programmed consequences. The essential value of heroin was significantly reduced in the groups that had either TOA or low-price heroin available on the second lever. Additionally, as the price of heroin on the first lever increased, consumption of TOA reinforcers or low-price heroin infusions increased, confirming that these were substitutes for expensive heroin. In Exp. 2, two groups of rats pressed one lever for heroin infusions on a series of increasing prices. One group could press a second lever for saccharin reinforcers at a constant low price. Concurrent saccharin availability increased demand for heroin in female rats, but not in male rats. Exp. 3 compared demand for saccharin in groups that had or did not have concurrent access to low-price heroin. Concurrent heroin availability caused an increase in estimated saccharin consumption at no cost (Q
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.